Switching from Olanzapine to Ziprasidone: a 12-Week, Open-Label, Multicenter Study Evaluating the Effectiveness and Safety of Ziprasidone in Patients with Schizophrenia.
T. Si,Y. P. Duan,Y. Su,W. Dang,H. Deng,M. Tao,T. Liu,H. Chen
DOI: https://doi.org/10.3969/j.issn.1009-7201.2013.01.002
2013-01-01
Journal of Psychiatry
Abstract:Objective To evaluate the effectiveness and safety of switching to ziprasidone from olanzapine because of inadequate response or intolerance.Methods A total of 100 patients with first-episode or non-refractory schizophrenia(diagnosed according with the criteria of DSM-IV) who had no response to olanzapine or showed poor tolerance to alanzapine were enrolled in a 12-week,open-label,flexible-dose ziprasidone trial.All patients were assessed with Positive and Negative Syndrome Scale(PANSS),Calgary Depression Scale(CDSS),global impression scale(CGI) and Social Functions(SF-12) at baseline and the end of 2nd,4th,8th,12th week to evaluate the efficacy.Extrapyramidal Side Effects Scale(SAS),laboratory examination and electrocardiogram examination were performed to evaluate the safety at baseline and the end of the 4th,8th week of the treatment.Results A total of 86 patients completed the trial.Scores of PANSS,CDSS,CGI and SF-12 all decreased significantly with the advance of the treatment(P0.001).61 complete records of adverse reactions were collected.The most common adverse reaction was extrapyramidal effect(32 cases,36.07%).The prevalence of relatively rare adverse reactions was 16.39%(10 cases),which consisted of agitation(2 cases),nausea(1 case),constipation(1 case),insomnia(1 case),dizziness(1 case),headache(1 case),anxiety(1 case),dry mouth(1 case) and tachycardia(1 case).There were no significant changes in fasting glucose,HbA1c,triglyceride,total cholesterol,prolactin,QTc interval,heart rate at different observation time-points with the advance of the treatment.Conclusion Ziprasidone can improve the clinical symptoms effectively in patients who had no response to olanzapine or showed poor tolerance to alanzapine.Ziprasidone has less adverse reactions and has little effect on metabolism.